VAXXINITY INC-A (VAXX) Stock Analyst Ratings
USA - NASDAQ:VAXX - US92244V1044 - Common Stock
0.1111 USD
-0.02 (-15.26%)
0.1107 USD
0 (-0.36%)
ChartMill assigns a Buy % Consensus number of 88% to VAXX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.3. This target is 13671.38% above the current price.
VAXX was analyzed by 8 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about VAXX.
In the previous month the buy percentage consensus was at a similar level.
VAXX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-09-08 | Baird | Initiate | Outperform |
| 2022-04-27 | Evercore ISI Group | Initiate | In-Line |
| 2021-12-07 | Jefferies | Initiate | Buy |
| 2021-12-06 | B of A Securities | Initiate | Buy |
VAXXINITY INC-A / VAXX FAQ
What do analysts expect the price target to be for VAXXINITY INC-A (VAXX)?
8 analysts have analysed VAXX and the average price target is 15.3 USD. This implies a price increase of 13671.38% is expected in the next year compared to the current price of 0.1111.
Can you provide the consensus rating for VAXXINITY INC-A stock?
The consensus rating for VAXXINITY INC-A (VAXX) is 87.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.